| Impax Laboratories Confirms Patent Challenge Relating to RENVELA(R), 2.4 g and ... - MarketWatch (press release) |
|
|
MarketWatch (press release)RENVELA(R) is indicated for the control of serum phosphorus in patients with Chronic Kidney Disease on dialysis. According to Wolters Kluwer Health, ... read more |